Latest in News & Research

24 of 905

Headline from the Week of October 21 - 27, 2024

FDA Approves EBGLYSS for Moderate-to-Severe Atopic Dermatitis in Adults and Adolescents

By Dermsquared Editorial Team | October 21, 2024

Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved